FDA Approves Supplemental Application for Capecitabine by Accord Healthcare
The FDA has approved a supplemental application for Capecitabine submitted by Accord Healthcare.
Therapeutic Area
Therapeutic area intelligence for Chemotherapy with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.